Thomas M. O’Dorisio

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors”.

It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors

Annals of Surgical Oncology(2020)10.1245/s10434-020-08784-0

N/A

0DataRank · unranked

25 citations

Scott K. Sherman, Aaron T. Scott, Po Hien Ear, Chandrikha Chandrasekharan, Andrew M. Bellizzi +4 more

Presacral neuroendocrine tumors associated with the Currarino syndrome

American Journal of Medical Genetics Part A(2021)10.1002/ajmg.a.62145

N/A

0DataRank · unranked

7 citations

Jonathon B. Tessmann, Terry A. Braun, Bartley Brown, Patrick Breheny, Benjamin W. Darbro +9 more

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy

Cancers(2022)10.3390/cancers14081910

N/A

0DataRank · unranked

22 citations

Luis C. Borbon, Jacqueline L. Mudd, Ellen Abusada, Solmaz AghaAmiri, Sukhen C. Ghosh +18 more

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy

Preprints.org(2022)10.20944/preprints202202.0090.v1

N/A

0DataRank · unranked

5 citations

Luis C. Borbon, Jacqueline L. Mudd, Ellen Abusada, Solmaz AghaAmiri, Sukhen C. Ghosh +18 more

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers

Radiation Research(2023)10.1667/rade-23-00064.1

N/A

0DataRank · unranked

10 citations

Dijie Liu, Jordan T. Ewald, Claudia Robles-Planells, Ann Tomanek‐Chalkley, Stephen A. Graves +8 more

Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors

Annals of Surgical Oncology(2024)10.1245/s10434-024-16463-7

N/A

0DataRank · unranked

5 citations

Scott K. Sherman, Patrick Breheny, Chandrikha Chandrasekharan, Yusuf Menda, David Bushnell +7 more